Literature DB >> 27902913

Regulatory Considerations for the Approval of Drugs Against Histomoniasis (Blackhead Disease) in Turkeys, Chickens, and Game Birds in the United States.

Prajwal R Regmi1, Ashley L Shaw1, Laura L Hungerford1, Janis R Messenheimer1, Tong Zhou1, Padmakumar Pillai2, Amy Omer3, Jeffrey M Gilbert1.   

Abstract

Histomoniasis, commonly referred to as blackhead disease, is a serious threat to the turkey and game bird industries worldwide, and it is having an increasingly negative impact on the chicken industry as well. The Food and Drug Administration's (FDA) Center for Veterinary Medicine (CVM), charged with the approval and regulation of new animal drugs in the United States, understands the rising need for the availability of therapeutic options against histomoniasis. CVM has actively engaged in discussions with the poultry industry, academic institutions, and animal health companies regarding the current status of histomoniasis in the United States and varied success of past and current management, prophylactic, and therapeutic interventions that have been used against the disease. As effective options against the disease are severely limited, CVM encourages the poultry industry, academic institutions, and animal health companies to work together to research and develop viable management, prophylactic, and therapeutic strategies, such as litter management, deworming programs, vaccines or other biologics, novel technologies, and animal drugs. CVM also recognizes the potential challenges that the poultry industry, academic institutions, and animal health companies may encounter while working towards the approval of safe and effective drug products for the treatment and control of histomoniasis. With that recognition, CVM encourages interested parties to begin discussions with CVM early in order to align research of the drug product against histomoniasis with the drug approval requirements, such that it leads to the approval of a new animal drug in an efficient and expedient manner. This article provides information about the FDA's regulatory process for the approval of new animal drugs in the United States, with especial emphasis on drug products for the treatment and control of histomoniasis in turkeys, chickens, and game birds.

Entities:  

Keywords:  FDA; Histomonas meleagridis; blackhead disease; chicken; drug approval; game bird; histomoniasis; treatment and control; turkey

Mesh:

Substances:

Year:  2016        PMID: 27902913     DOI: 10.1637/11451-061516-Review.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  5 in total

1.  Causes of mortality in backyard poultry in eight states in the United States.

Authors:  Kyran J Cadmus; Aslı Mete; Macallister Harris; Doug Anderson; Sherrill Davison; Yuko Sato; Julie Helm; Lore Boger; Jenee Odani; Martin D Ficken; Kristy L Pabilonia
Journal:  J Vet Diagn Invest       Date:  2019-05       Impact factor: 1.279

2.  Feed Composition and Isolate of Histomonas meleagridis Alter Horizontal Transmission of Histomonosis in Turkeys. Proof of Concept.

Authors:  Thaina L Barros; Christine N Vuong; Juan D Latorre; Roberto S Cuesta; Elizabeth McGill; Samuel J Rochell; Guillermo Tellez-Isaias; Billy M Hargis
Journal:  Front Vet Sci       Date:  2022-06-28

Review 3.  Histomonosis in Poultry: A Comprehensive Review.

Authors:  Lesleigh C Beer; Victor M Petrone-Garcia; B Danielle Graham; Billy M Hargis; Guillermo Tellez-Isaias; Christine N Vuong
Journal:  Front Vet Sci       Date:  2022-05-06

4.  Research Note: Evaluation of deoxycholic acid for antihistomonal activity.

Authors:  L C Beer; J D Latorre; S J Rochell; X Sun; G Tellez; A L Fuller; B M Hargis; C N Vuong
Journal:  Poult Sci       Date:  2020-04-25       Impact factor: 3.352

Review 5.  Role of Physiology, Immunity, Microbiota, and Infectious Diseases in the Gut Health of Poultry.

Authors:  Samiru S Wickramasuriya; Inkyung Park; Kyungwoo Lee; Youngsub Lee; Woo H Kim; Hyoyoun Nam; Hyun S Lillehoj
Journal:  Vaccines (Basel)       Date:  2022-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.